603439.SH
三力制药
SSE · Healthcare · Biotechnology · CN
CNY 12.12
−2.34%Margins
Gross margin
71.4%
EBITDA margin
8.2%
EBIT margin
4.1%
Net margin
2.9%
FCF margin
10.0%
3.3%
Return on equity
1.7%
Return on assets
3.2%
Return on invested capital
0.59x
Asset turnover
CNY 193.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026